Member Login | About | Contact
American Association of Oral and Maxillofacial Surgeons
AAOMS 91st Annual Meeting, Scientific Sessions and Exhibition

Surgical Mini-Lectures and Clinics


Warning: mysql_pconnect() [function.mysql-pconnect]: Access denied for user 'db47061'@'72.47.224.25' (using password: YES) in /nfs/c03/h01/mnt/47061/domains/aaoms.org/html/annual_meeting/2009/surgical_clinics.php on line 31

Wednesday, September 29, 2010
2:00PM - 4:00PM

M614

Factors, Recognition, Prevention, and Treatment of Bisphosphonate Induced Osteonecrosis of the Jaws

Handouts Not
Currently Available

Vishtasb Broumand, DDS, MD
Private Practice
Daytona Beach, FL

Robert E. Marx, DDS
Professor of Surgery and Chief, Division of Oral and Maxillofacial Surgery, University of Miami Miller School of Dental Medicine
Miami, FL

Synopsis

Intravenous bisphosphonates prescribed for cancer patients and oral bisphosphonates prescribed for patients with osteoporosis are both known to produce osteonecrosis of the jaws. However, effective protocols have been developed to prevent a large number of patients from developing osteonecrosis and to treat it should it develop. Oral bisphosphonate osteonecrosis is less common, less severe. and more amendable to surgical resolution. In addition, oral bisphosphonate affects on bone can be assessed through straightforward blood testing which is useful in guiding surgery treatment decisions.

Learning Objectives

At the conclusion of this presentation, participants should be able to:

  1. Gain an understanding of bone remodeling renewal and its dependance on osteoclasts function and stimulation of the osteoblast;
  2. Prevent osteonecrosis in developing in their own patients and are able to teach fellow oral and maxillofacial surgeons and dentists these effective protocols. Participants effectively treat osteonecrosis of the jaws and are able to teach fellow oral and maxillofacial surgeons and dentists how to manage these patients. Participants effectively treat osteonecrosis of the jaws and are able to teach fellow oral and maxillofacial surgeons and dentist how to manage these patients; and
  3. Prevent osteonecrosis from oral bisphosphonate in their patients who require surgery.

» Back to Surgical Mini-Lectures and Clinics